Following the deaths of children linked to contaminated cough syrups, there is an urgent call to reform the regulatory framework for pediatric medicines in India. Children are not 'small adults'; their physiological responses to drugs differ significantly, yet many dosages are currently extrapolated from adult guidelines. The article emphasizes the need for specific pediatric clinical trials and stricter oversight by the Central Drugs Standard Control Organisation (CDSCO). It advocates for a holistic framework to monitor medicine use, better pharmacovigilance, and the adoption of the WHO’s Essential Medicine List for children to ensure affordable and safe healthcare for the younger population.
- Children require specific drug formulations and dosages because their pharmacodynamic responses differ from those of adults.
- Article 39(f) of the Indian Constitution mandates the state to ensure children are protected against exploitation and given opportunities for healthy development.
- India lacks a specific policy or legislation for pediatric drug research, often relying on general guidelines or adult data extrapolation.
A new paper in 'The Lancet Infectious Diseases' reveals a critical health crisis in Gaza: a surge in multidrug-resistant (MDR) infections. Tests on samples from Al-Ahli Arab Hospital show that over two-thirds of bacterial isolates are resistant to multiple antibiotics. Factors contributing to this include the depletion of broad-spectrum antibiotics, overcrowded conditions for displaced people, and the nature of ballistic/crush injuries. Common pathogens like Pseudomonas aeruginosa and Klebsiella are showing high resistance to standard treatments. The destruction of healthcare infrastructure and lack of clean water further exacerbate the spread of these 'superbugs,' posing a long-term public health threat.
- Over two-thirds of bacterial samples from Gaza show resistance to multiple antibiotics, complicating trauma care.
- Ballistic and crush injuries are particularly prone to hospital-acquired infections like Pseudomonas aeruginosa.
- The collapse of the healthcare system and lack of microbiology labs hinder effective antibiotic stewardship.
The UN State of World Population 2025 report indicates India’s Total Fertility Rate (TFR) has fallen to 1.9, below the replacement level of 2.1. However, this article questions whether this figure reflects reality due to the limitations of the 'synthetic cohort' assumption used in TFR calculations. TFR is sensitive to 'tempo effects'—changes in the timing of childbearing—which can artificially lower the rate if women postpone births. Data from NFHS rounds shows a shift in fertility preferences, with a decline in births among younger cohorts and an increase in older cohorts, suggesting that India's demographic transition is complex and varied across regions.
- TFR is a statistical measure calculating the average number of children a woman would have based on current age-specific fertility rates (ASFR).
- Postponement of marriage and childbearing (tempo effect) can lead to an underestimation of the actual number of children women will eventually have.
- The gap between real and calculated TFR is particularly significant in developing countries undergoing rapid socio-economic changes.
This article critiques India's environmental monitoring systems, specifically Delhi’s Real-Time Air Pollution Network and Lucknow’s National Ambient Noise Monitoring Network. It argues that scientific weaknesses and misleading data 'moderate' hazardous levels, eroding public trust and undermining policy. The lack of independent audits and transparent processes allows agencies to divert focus from accountability. The author emphasizes that sound data is essential for meeting global commitments like the Paris Agreement and WHO standards. Furthermore, noise pollution is highlighted as a constitutional and public health issue rather than just a nuisance.
- Flawed monitoring data compromises the effectiveness of action plans for stubble burning and industrial emissions.
- Misleading Air Quality Index (AQI) reports often delay judicial and policy interventions.
- The Supreme Court recently recognized noise pollution as a constitutional issue under Articles 19 and 21.
The National Health Authority's annual report for 2024-25 indicates that women constitute 49% of total hospital admissions under the Ayushman Bharat-Pradhan Mantri Jan Arogya Yojana (AB-PMJAY). This reflects a significant improvement in institutional healthcare access for women. The scheme, launched in 2018, provides ₹5 lakh annual health cover per family and has facilitated over 9.19 crore admissions. Recent expansions include the 'Aapke Dwar Ayushman (ADA 3.0)' initiative for grassroots outreach and the inclusion of all senior citizens aged 70 and above, regardless of their socio-economic status, as of October 2024.
- Women represent nearly half of all beneficiaries receiving hospital treatment under the AB-PMJAY scheme.
- The scheme provides a health cover of ₹5 lakh per family per year for secondary and tertiary care.
- The ADA 3.0 initiative leverages technology and community campaigns to increase scheme enrollment.
Kerala is grappling with an outbreak of amoebic meningoencephalitis, with the death toll rising to 26 and total cases reaching 129 this year. Health officials have identified Acanthamoeba as the causative pathogen, which can enter the human body through skin wounds when they come into contact with contaminated water bodies like streams or resort pools. Currently, 53 individuals are undergoing treatment. Thiruvananthapuram has reported the highest concentration of cases. Epidemiological investigations highlight that unlike some other amoebic infections, this strain can infect individuals through non-nasal routes, specifically open injuries.
- Amoebic meningoencephalitis is a severe brain infection caused by free-living amoebae found in water.
- The Acanthamoeba pathogen can enter the body through skin wounds, not just the nasal passage.
- Kerala has recorded 129 cases and 26 deaths so far in the current year.
A study published in Nature Medicine has confirmed the effectiveness of Rotavac, India's indigenous oral rotavirus vaccine. Conducted across 31 hospitals in nine states between 2016 and 2020, the study found a 54% reduction in rotavirus-based gastroenteritis hospitalizations. Rotavac was introduced into India's Universal Immunization Programme (UIP) in 2016 and is administered at 6, 10, and 14 weeks of age. The vaccine was developed through a public-private partnership involving the Department of Biotechnology and Bharat Biotech. Rotavirus is a leading cause of death in children under five, accounting for approximately 128,500 deaths annually.
- Rotavac is an indigenous oral vaccine provided free to beneficiaries under the Universal Immunization Programme (UIP).
- The vaccine showed 54% effectiveness in real-world conditions, matching phase 3 clinical trial results.
- It is administered in three doses at 6, 10, and 14 weeks of age.
Modern life, characterized by constant social media notifications and short-form videos, is causing a 'dopamine overdose' that rewires the brain. Dopamine, the 'feel-good' neurotransmitter, drives the reward system, but excessive digital stimulation desensitizes the brain, leading to addictive behaviors, anxiety, and depression. Adolescents are particularly vulnerable due to high brain plasticity. The article suggests 'dopamine fasting'—taking breaks from high-stimulation digital devices—to recalibrate the brain's reward system. Engaging in slower, meaningful activities like reading, exercise, and face-to-face social interaction can help restore balance, improve attention spans, and enhance overall mental well-being in a hyper-stimulated world.
- Dopamine is a neurotransmitter that drives motivation and reward, but can be hijacked by addictive digital stimuli.
- Digital platforms use behavioral engineering to trigger reward circuits, leading to compulsive usage and fractured attention.
- Adolescents spending over three hours daily on social media report significantly higher levels of anxiety and depression.
The Union Health Ministry clarified that Kerala will receive an All India Institute of Medical Sciences (AIIMS) only after March 2026, coinciding with the next phase of the Pradhan Mantri Swasthya Suraksha Yojana (PMSSY). The current phase ends in March 2026. The Centre plans to set up an AIIMS in each state in phases. While the Kerala government has identified sites like Kinalur in Kozhikode, none have been officially approved yet. The disclosure suggests a decision is unlikely during the tenure of the current state government.
- AIIMS setup is part of the phased implementation of the Pradhan Mantri Swasthya Suraksha Yojana (PMSSY).
- The project is dependent on the Ministry of Finance granting in-principle approval for the next phase.
- The Kerala state government has set aside 150 acres in Kozhikode for the proposed institute.
India's biotech industry has grown from 500 startups in 2018 to over 10,000 in 2025, supported by the BioE3 Policy. India aims for a $300-billion bioeconomy by 2030. While India is a global leader in generics and vaccines, the sector faces challenges like regulatory complexities, high capital requirements for Phase II clinical trials, and a 'brain drain' of talent. The article suggests a dedicated biotechnology fund, blended-finance structures, and streamlined regulations to help startups scale and compete globally in high-impact areas like precision medicine.
- The BioE3 Policy aims to transform India into a $300-billion bioeconomy powerhouse by 2030.
- India provides over 60% of global doses for essential immunizations like DPT and BCG.
- Scaling challenges include fragmented infrastructure and the high cost of clinical validation for startups.
A study by CSIR-NIO and the Academy of Scientific and Innovative Research found significant microplastic contamination in fish along the Goa coast. Researchers identified 4,871 particles of 19 different types of polymers in 251 fish samples. Microplastics, primarily from fishing gear, tires, and wastewater, accumulate in the food chain through bioaccumulation. The study warns that human consumption of contaminated fish may lead to immune dysfunction, increased cancer risk, and neurotoxicity. The findings underscore the urgent need for better waste disposal and research into biodegradable alternatives to protect marine ecosystems and public health in coastal regions.
- Microplastics enter the food chain and accumulate in higher organisms, a process known as bioaccumulation.
- The study found higher contamination on the sea floor and in benthic organisms compared to the water column.
- Common polymers found include those from fishing gear, textiles, and road residue.
The World Health Organization (WHO) has issued a medical product alert for three liquid medicines—Coldrif, Respifresh TR, and ReLife—identified in India as contaminated. These products, manufactured by Sresan Pharmaceutical, Rednex Pharmaceuticals, and Shape Pharma, were found to contain diethylene glycol, which is toxic and potentially fatal to humans. The CDSCO has informed WHO that these batches have not been exported from India. Regulatory authorities have been advised to increase market surveillance to prevent these substandard products from reaching consumers through informal or unregulated supply chains, as they pose significant risks to public health.
- Diethylene glycol is a toxic contaminant found in oral liquid medicines that can cause life-threatening illness.
- The CDSCO (Central Drugs Standard Control Organisation) is the Indian regulatory body monitoring the situation.
- Substandard products failed to meet quality standards and specifications for active ingredients used for common colds.
Thalassemia patients in Kerala are reporting a decline in hemoglobin levels due to a shortage of leukocyte filter sets, which prevent adverse reactions during blood transfusions. Additionally, iron chelation drugs, necessary to remove excess iron deposited in organs after transfusions, have been unavailable for a year. While the government has issued orders for local procurement, authorities are allegedly ignoring these directives. The shortage is attributed to financial crunches, though new tenders have been called. Thalassemia is an inherited blood disorder where the body fails to produce enough hemoglobin, requiring lifelong regular transfusions to maintain oxygen levels in the blood.
- Thalassemia is a genetic disorder affecting hemoglobin production in red blood cells, leading to chronic anemia.
- Regular blood transfusions lead to iron overload, necessitating iron chelation therapy to protect vital organs like the heart and liver.
- Leukocyte filters are critical during transfusions to minimize adverse immune reactions and maintain hemoglobin stability.
The 2025 Nobel Prize in Physiology or Medicine was awarded to Mary E. Brunkow, Fred Ramsdell, and Shimon Sakaguchi for their groundbreaking work on regulatory T cells (Tregs). Their research explained how the immune system maintains 'peripheral tolerance,' preventing it from attacking the body's own tissues. They identified the Foxp3 gene as the master controller for Treg development. Mutations in this gene lead to IPEX, a severe autoimmune disease. This discovery has paved the way for new treatments for cancer, where Tregs are dismantled to allow immune attacks on tumors, and autoimmune disorders, where Treg growth is encouraged.
- Regulatory T cells (Tregs) act as a 'security guard' to prevent the immune system from attacking healthy cells.
- The Foxp3 gene is essential for the production and function of these regulatory cells.
- The discovery helps explain why most people do not develop autoimmune conditions despite a powerful immune system.
Antimicrobial Resistance (AMR) is being reframed as a communication crisis rather than just a medical one. Since the 2010 discovery of the NDM-1 enzyme, the focus has been on alarming global statistics, which often leads to public apathy. Experts now advocate for a narrative centered on the 'human microbiome'—the trillions of beneficial microbes that are disrupted by unnecessary antibiotic use. By emphasizing how antibiotics can harm individual health, immunity, and mental well-being, health advocates hope to move from a 'language of war' against bugs to a 'language of wisdom' in preserving life-saving drugs.
- NDM-1 (New Delhi Metallo-beta-lactamase) brought global attention to AMR in 2010.
- Unnecessary antibiotic use can disrupt the human microbiome for months, affecting long-term health.
- Reframing AMR as a solvable, individual health challenge is more effective than using abstract, large-scale statistics.
The Central Drugs Standard Control Organisation (CDSCO) has ordered a joint audit of cough syrup manufacturers across India. This regulatory action follows the identification of three contaminated syrups—Coldrif, Respifresh, and Re-Life—containing diethylene glycol (DEG), which have been linked to child deaths. While these products were marketed domestically and not exported, the WHO has flagged a 'regulatory gap' in screening for DEG and ethylene glycol (EG) in India. The audit aims to identify manufacturers, stop production of unsafe medical products, and tighten domestic quality control standards in the pharmaceutical industry.
- Diethylene glycol (DEG) is a highly toxic contaminant that can cause kidney failure and death.
- The CDSCO is working with State governments to create a comprehensive list of all domestic cough syrup makers.
- The World Health Organization (WHO) is supporting Indian authorities in investigating the source of contamination.
India is facing a severe mental health crisis, with the 2023 ADSI report recording 1,71,418 suicides. Despite the Mental Healthcare Act 2017 decriminalizing suicide and guaranteeing the right to care, significant gaps remain. The country has only 0.75 psychiatrists per 1,00,000 people, far below the WHO recommendation of 3. Experts call for increasing the mental health budget to 5% of total health expenditure and establishing a cross-ministerial task force. The economic impact of mental health issues in India is projected to exceed $1 trillion by 2030, necessitating urgent decentralization and community-based interventions.
- Suicide is the leading cause of death among Indian youth aged 15-29 years.
- The treatment gap for mental disorders in India is estimated between 70% and 92%.
- Tele-MANAS and Manodarpan are key government initiatives for digital mental health support and school-based counseling.
Despite the Union Health Ministry's efforts to upgrade pharmaceutical standards, no Indian state has fully complied with the Corrective and Preventive Action (CAPA) guidelines. These guidelines are a crucial part of the revised Schedule M of the Drugs and Cosmetics Rules, aimed at ensuring global quality standards. While 18 states have adopted the Online National Drugs Licensing System (ONDLS), the implementation of CAPA remains voluntary and slow. This lack of compliance is concerning given recent international incidents involving adulterated Indian-made cough syrups. The Ministry emphasizes that CAPA is essential for systematic investigation and resolution of manufacturing defects.
- The revised Schedule M is a critical update to India’s pharmaceutical manufacturing regulations to ensure safety and quality.
- CAPA (Corrective and Preventive Action) is a universal quality management methodology for process improvement in the pharma industry.
- The ONDLS is a single-window digital platform developed by CDAC and CDSCO for transparent drug licensing across India.
The 2025 Nobel Prize in Physiology or Medicine was awarded to Mary Brunkow, Fred Ramsdell, and Shimon Sakaguchi for their groundbreaking work on autoimmune regulation. They identified the role of regulatory T-cells (Tregs) and the transcription factor FOXP3. Sakaguchi discovered Tregs in 1995, while Brunkow and Ramsdell identified the FOXP3 gene. Mutations in FOXP3 lead to IPEX, a lethal autoimmune disorder. Their research transformed the understanding of the immune system from a simple on/off switch to a dynamic ecosystem of activation and restraint, opening doors for new treatments for cancer and autoimmune diseases.
- The laureates identified regulatory T-cells (Tregs) which prevent the immune system from attacking the body's own cells.
- The FOXP3 gene was identified as the master regulator for the development and function of Tregs.
- This discovery has significant implications for treating autoimmune diseases, cancer, and improving organ transplant success.
The Union Health Ministry is pushing for strict drug compliance following reports of contaminated cough syrups. The Tamil Nadu Drugs Control Department found diethylene glycol (DEG) and ethylene glycol in samples of Coldrif, a cough syrup linked to child deaths in Rajasthan and Madhya Pradesh. These substances are nephrotoxic and highly dangerous. The Central Drugs Standard Control Organisation (CDSCO) has recommended cancelling the firm's manufacturing license. The article emphasizes the need for a zero-tolerance policy, hawk-like monitoring, and regular surprise inspections to uphold the 'Make in India' brand and protect public health from substandard pharmaceutical products.
- Contaminated cough syrups containing DEG and ethylene glycol have been linked to multiple child deaths in India.
- The CDSCO has recommended the cancellation of manufacturing licenses for firms failing to meet quality standards.
- Revised Schedule M norms are being implemented to ensure Indian pharmaceutical products meet global Good Manufacturing Practices (GMP).
The Union Health Ministry has directed drug manufacturers to strictly comply with the revised Schedule M norms under the Drugs and Cosmetics Act, 1940. This move follows reports of toxic cough syrups causing child deaths in Madhya Pradesh and Rajasthan. The revised norms mandate enhanced quality systems, including Pharmaceutical Quality Systems (PQS) and Quality Risk Management (QRM). Non-compliant units face license cancellation. The goal is to align Indian manufacturing standards with international Good Manufacturing Practices (GMP) to ensure product safety, prevent contamination like diethylene glycol (DEG), and maintain the global reputation of Indian pharmaceuticals.
- Schedule M of the Drugs and Cosmetics Act, 1940, prescribes the Good Manufacturing Practices (GMP) for pharmaceutical products in India.
- The revision introduces computerized storage systems and equipment validation to prevent contamination.
- Recent investigations found high levels of diethylene glycol (DEG) in 'Coldrif' cough syrup, leading to immediate production stops.
India faces a significant but underestimated burden of influenza, with two distinct seasonal peaks: winter (January-March) and post-monsoon (July-September). Current influenza vaccines provide short-lived protection, with antibody levels declining significantly within three to six months. Because the virus undergoes constant antigenic drift, experts suggest that a single annual shot is insufficient for year-round protection in India's tropical climate. The article advocates for a biannual vaccination schedule (June and November) and the inclusion of influenza vaccines in the Universal Immunisation Programme (UIP) to reduce hospitalisations and deaths, particularly among children and the elderly who are most at risk.
- India experiences two influenza peaks, unlike temperate countries which typically have one winter peak.
- Vaccine effectiveness drops significantly within 90 days, leaving populations vulnerable during the second annual peak.
- Less than 5% of Indians currently receive influenza vaccines due to a lack of government policy and public awareness.
The Union Health Ministry has launched risk-based inspections of 19 drug manufacturing units after the Tamil Nadu Drugs Control Department found diethylene glycol (DEG) above permissible limits in 'Coldrif' cough syrup. Produced by Sresan Pharmaceuticals in Kancheepuram, the syrup is linked to at least 10 child deaths in Madhya Pradesh and Rajasthan. While the Central Drugs Standard Control Organisation (CDSCO) initially found some samples free of DEG, state authorities in MP and Kerala have prohibited its sale. DEG and ethylene glycol are toxic industrial solvents sometimes used as cheap, illegal substitutes for pharmaceutical-grade glycerine, leading to severe health risks including renal failure.
- The Tamil Nadu Drugs Control Department identified a batch of Coldrif as 'not of standard quality' due to DEG adulteration.
- Diethylene glycol (DEG) is a poisonous substance that can cause renal failure and death, especially in children.
- The Union Health Ministry is conducting risk-based inspections across six states to identify quality failures in pharma units.
A conflict has emerged between Central and State health authorities regarding cough syrup safety. The Union Health Ministry stated that samples linked to child deaths in Madhya Pradesh and Rajasthan did not contain Diethylene Glycol (DEG) or Ethylene Glycol (EG). Conversely, Tamil Nadu's Drugs Control Department ordered a production halt for 'Coldrif' syrup after tests detected DEG adulteration. The Centre attributed some deaths to other causes like leptospirosis or improper home administration. An advisory has been issued cautioning against prescribing cough syrups to children under two years old and emphasizing the need for medical supervision.
- The Union Health Ministry claims samples tested by the NIV and CDSCO did not show toxic contaminants like DEG or EG.
- Tamil Nadu's Government Drugs Testing Laboratory found a batch of Coldrif syrup to be 'not of standard quality' due to DEG presence.
- Health authorities have issued a show-cause notice to Sresan Pharmaceutical, the manufacturer of the suspected Coldrif batch.